GLP-1 boom feeds into side effects market

Meanwhile, the Economic Times daily newspaper is available online now.

Key points

• (Catch all the Business News, Breaking News and Latest News Updates on The Economic Times.).
• Sugar Cosmetics and HUL's Lakme are pushing plumping, non-invasive make-up alternatives such as lip fillers.
• The India unit of Nestle remarked it is working through its joint venture with Dr.
• GLP-1 drugs create new market for collagen, protein and beauty products in India.
• Reddy's laboratoriescollagen supplementsOzempiccollagen skincareweight loss medicationsMounjarobeauty products IndiaNestle Health Science.

GLP-1 drugs create new market for collagen, protein and beauty products in India. ET BureauLast Updated: Aug 21, 2026, 12: 49: 00 AM IST.

Notably, the rising employ of GLP-1 weight-loss drugs such as Ozempic and Mounjaro is creating a new consumer market in India, with businesses developing protein- and fibre-rich foods, nutrition supplements and beauty products aimed at addressing side effects of rapid weight loss.

New Delhi: Firms are rushing to launch products ranging from foods and beverages to face fillers and collagen skincare supplements to capitalise on the side effects of increasingly popular weight-loss drugs such as glucagon-like peptide-1 (GLP-1) medications Ozempic and Mounjaro. "This is the biggest new demand driver beauty has had in a decade, and it's coming out of a pharmacy, not a trend cycle, " remarked Radhika Ghai, founder of premium cosmetics e-commerce platform Kindlife. With face fillers, supplements and other products, brands cater to widening demand.

"When individuals lose weight this fast, the medication takes facial volume, skin elasticity and hair along with the fat, so everyone who starts a GLP-1 eventually becomes a customer for a highly specific set of products, such as barrier repair, collagen-support skincare and firming body care. What makes this different is that demand grows with the patient base, instead of fading with the season."

Rapid weight loss as a side effect of GLP-1 drugs, a group of prescription medicines applied to treat type 2 diabetes and backing weight loss, not only depletes body fat but additionally leads to distinct loss of protein and fibre, a gap businesses are competing to be the first ones to fill with nutrition-dense foods and make-up. Sugar Cosmetics and HUL's Lakme are pushing plumping, non-invasive make-up alternatives such as lip fillers. Live Events.

For context, the India unit of Nestle remarked it is working through its joint venture with Dr. Reddy's Laboratories to introduce multiple products for individuals using GLP-1 drugs by addressing nutrition gaps. "The joint venture between Nestle Health Science and Dr. Reddy's Laboratories has taken a significant step in this space with Celevida GLP+ (a nutrition supplement) for individuals undergoing GLP-1 therapy, " stated a spokesperson. Tata Consumer Products is additionally readying to enter the segment. Its managing director Sunil D'Souza informed ET in July that the business was looking to introduce waters and snacks with protein and fibre to support consumers manage weight-loss side effects by supplementing their food intake. Since of increasing consumption of GLP-1 products, residents consume less protein, fibre, prebiotics and probiotics, "We are working towards how to play in this space where. We are not looking at reducing portion sizes. Instead, over the next 60 days, we will start entering multiple foods and beverages categories to manage weight loss side effects, where consumers are looking to supplement their food intake, " he remarked. Add Now!

Dr. Reddy's laboratoriescollagen supplementsOzempiccollagen skincareweight loss medicationsMounjarobeauty products IndiaNestle Health Science.

(Catch all the Business News, Breaking News and Latest News Updates on The Economic Times.). Dr. Reddy's laboratoriescollagen supplementsOzempiccollagen skincareweight loss medicationsMounjarobeauty products IndiaNestle Health Science.

In short, GLP-1 boom feeds into side effects market is the central thread here, and readers can expect follow-up reporting as the picture becomes clearer.